Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ABC on COLD-fX

This article was originally published in The Tan Sheet

Executive Summary

A "major scientific review" of COLD-fX Pharmaceuticals' eponymous product finds the cold and flu remedy provides "impressive benefits," according to a March 1 release from the American Botanical Council. The review of published scientific and clinical studies on the product's active ingredient CVT-E002 found evidence that the product may offer prevention efficacy and suggest the product may help prevent acute respiratory infection. CVT-E002 is a proprietary herbal preparation made from the roots of North American ginseng. Bruce Barrett, M.D., University of Wisconsin, et al., also conclude they "could find no evidence of any risks that would require label warnings." COLD-fX is promoted by the National Hockey League (1"The Tan Sheet" Oct. 23, 2006, In Brief)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100285

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel